Investors of Align Technology Launch Lawsuit
Law Offices of Howard G Smith, representing investors of Align Technology (Align) has filed a class action lawsuit in US District Court for the Northern District of California

Law Offices of Howard G Smith, representing investors of Align Technology (Align) has filed a class action lawsuit in US District Court for the Northern District of California

The FDA has issued warning letters to eight companies marketing unlawful over-the-counter (OTC) topical drug products, containing the pain reliever – ibuprofen. According to the FDA, the products,

W R Grace & Co. has inaugurated its new facility in Rowville, Australia. The site will operates as part of Grace Davison Discovery Sciences, and is likely to

Skystar has initiated early-stage field experiments of its proprietary – Methionine Enkephalin (Met-Enk) powder. Met-Enk is designed to boost the immune system of livestock, which helps animals’ immune

Wake Pharma (Wake) has received American Podiatric Medical Association (APMA) seal of approval for its product – Wound-Be-Gone, based on a new oxygen free radical binding technology. Wound-Be-Gone

SOCMA has recommended its members to look at the progression of the Consumer Product Safety Improvement Act of 2008 (CPSIA), as the Kid-Safe Chemicals Act next month is

Medicago has signed a memorandum of understanding (MOU) with Ajanta Pharma, to negotiate an agreement to commercialize Medicago’s pandemic and seasonal influenza VLP-based vaccines in India and other

Bristol-Myers Squibb has extended its previously announced cash tender offer, through its wholly-owned subsidiary Puma Acquisition Corporation (Puma), to purchase all outstanding shares of common stock of Medarex

Anika Therapeutics (Anika) has received approval from Health Canada for Monovisc, its single injection viscosupplement, for the treatment of osteoarthritis of the knee. Anika expects to launch Monovisc

XSpray Microparticles has launched its new GMP production facility in Malmo, Sweden. With the introduction of this new plant, XSpray is expected to provide quality drug particles and